Vivos Therapeutics (VVOS) Current Leases (2021 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Current Leases of $56000.0 for Q1 2026, down 88.01% year-over-year from $467000.0 in Q1 2025, and up 1.82% quarter-over-quarter from $55000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Current Leases (2021 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Current Leases for 6 consecutive years, with $56000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 88.01% year-over-year to $56000.0; the TTM figure through Mar 2026 stood at $56000.0 (down 88.01% YoY), while the FY2025 annual figure was $55000.0, down 88.47% from the prior year.
- Current Leases improved to $56000.0 in Q1 2026 per VVOS's latest filing, from $55000.0 in the prior quarter.
- Across five years, Current Leases topped out at $485000.0 in Q3 2024 and bottomed at $55000.0 in Q2 2025.
- Historically, Current Leases has averaged $355058.8 across 5 years, with a median of $446000.0 in 2022.
- Annual changes were most pronounced in 2022 — Current Leases jumped 481.94% — and 2025, when it plunged 88.66%.
- Vivos Therapeutics' Current Leases stood at $419000.0 in 2022, then advanced by 13.13% to $474000.0 in 2023, then climbed by 0.63% to $477000.0 in 2024, then plunged by 88.47% to $55000.0 in 2025, then increased by 1.82% to $56000.0 in 2026.
- Business Quant data shows VVOS's Current Leases at $56000.0 in Q1 2026, $55000.0 in Q4 2025, and $55000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 24.10 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 20.70 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 35.60 Mn |
| 10 | Vivos Therapeutics | 4.94 Mn | 3.14 Mn | 2.95 Mn | 790,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 55,000.00 |
| Sep 30, 2025 | 55,000.00 |
| Jun 30, 2025 | 55,000.00 |
| Mar 31, 2025 | 467,000.00 |
| Dec 31, 2024 | 477,000.00 |
| Sep 30, 2024 | 485,000.00 |
| Jun 30, 2024 | 484,000.00 |
| Mar 31, 2024 | 483,000.00 |
| Dec 31, 2023 | 474,000.00 |
| Sep 30, 2023 | 460,000.00 |
| Jun 30, 2023 | 447,000.00 |
| Mar 31, 2023 | 433,000.00 |
| Dec 31, 2022 | 419,000.00 |
| Sep 30, 2022 | 446,000.00 |
| Jun 30, 2022 | 383,000.00 |
| Mar 31, 2022 | 357,000.00 |
| Dec 31, 2021 | 72,000.00 |